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Abstract
This systematic review identifies models of service co-location, a structural intervention strategy 
to remove barriers to HIV care and services, and examines their associations with HIV care 
outcomes. A cumulative database (e.g., MEDLINE, EMBASE) of HIV, AIDS, and STI literature 
was systematically searched and manual searches were conducted to identify relevant studies. 
Thirty-six studies were classified into six models of co-location: HIV care co-located with 
multiple ancillary services, tuberculosis (TB) care, non-HIV specific primary care, drug abuse 
treatment, prevention of mother to child transmission programs (PMTCT), and mental health care. 
More evidence of a positive association was seen for linkage to care and antiretroviral therapy 
(ART) uptake than for retention and viral suppression. Models of co-location that addressed HIV 
and non-HIV medical care issues (i.e., co-location with non-HIV specific primary care, PMTCT, 
and TB) had more positive associations, particularly for linkage to care and ART uptake, than 
other co-location models. While some findings are encouraging, more research with rigorous study 
designs is needed to strengthen the evaluation of, and evidence for, service co-location.
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INTRODUCTION
Antiretroviral therapy (ART) has been proven not only to improve health outcomes for 
persons with HIV (PWH) but also to substantially reduce the risk of sexual transmission of 
HIV (Cohen et al., 2011). With the advent of this powerful biomedical prevention tool, HIV 
prevention planners are now poised to maximize the number of PWH who are linked to and 
retained in care for sustained viral suppression. Addressing structural-level barriers to care, 
particularly access to HIV care, through service integration (CDC, 2009; CDC, 2012; World 
Health Organization (WHO), 2012), may be one of the important strategies to consider.
Co-location of services (hereafter referred to as “service co-location”) is one model of 
service integration or one of the steps towards comprehensive service integration (Carter et 
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al., 2013; Sweeney et al., 2012; Sylla, Bruce, Kamarulzaman & Altice, 2007). Also referred 
to as a “one-stop shopping” model of service delivery, service co-location aims to facilitate 
patients’ access to multiple services by offering them onsite in a single location (Carter et 
al., 2013; Johnson et al., 2003). Thus, it is expected to remove structural/physical barriers to 
care and services (e.g., lack of transportation, services provided in separate locations) and to 
simultaneously address multiple co-occurring clinical and social service needs of PWH 
(Bauman et al., 2013; Mizuno et al., 2015). A previous meta-analysis (Suthar, Rutherford, 
Horvath, Doherty, & Negussie, 2014) has shown that integrating ART into maternal, 
newborn and child health care, tuberculosis (TB), and opiate substitution therapy services 
was associated with improvements in ART coverage. To our knowledge, no systematic 
review has comprehensively examined the associations between a variety of service co-
location models and HIV care outcomes, including linkage to HIV care, retention in HIV 
care, ART uptake, and viral suppression among PWH.
The purpose of this systematic review is to examine the following research questions: 1) 
what models of service co-location have been studied; and 2) is service co-location 
positively associated with better HIV care outcomes (e.g., higher rates of linkage, retention, 
ART uptake, and viral suppression)?
METHODS
Database and search strategy
We searched the CDC’s Prevention Research Synthesis (PRS) project cumulative database 
of HIV, AIDS, and STI literature (Reference Hidden). The database was comprised of 
citations located through four comprehensive search strategies implemented annually to 
identify 1) behavioral risk reduction interventions; 2) medication adherence interventions; 3) 
linkage to, retention in and re-engagement in HIV medical care interventions; and 4) HIV 
prevention related systematic reviews. The four strategies were used in systematic searches 
in MEDLINE, CINAHL, EMBASE, Global Health, PsycINFO and Sociological Abstracts 
databases and in on-going manual searches (reference list checks, hand searches, etc.). 
Librarians with systematic search experience developed and tested each search in 
MEDLINE and translated the searches to the other databases (DeLuca et al., 2011). As of 
April 2016, these searches collected over 77,000 citations from 1988 through 2016. (See 
Appendix for the MEDLINE search for each of the four strategies).
For this review, we developed a list of more than 60 co-location terms to search title, abstract 
and keywords of each citation in the PRS database as of April 2016 (see Appendix for full 
list of terms used to search the PRS database). Additional manual searches for this review 
were performed by checking the references of pertinent studies and the references of 
previously published systematic reviews on the HIV care to obtain relevant studies.
Study selection criteria
Studies were eligible for this systematic review if they: 1) examined service co-location, 
defined as offering at least one other service (e.g., medical care for another disease or 
condition, ancillary service such as case management, transportation, insurance assistance, 
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etc.) at the same facility as PWH received their HIV medical care (Liau et al., 2013); 2) 
reported any relevant HIV care outcome: linkage to care (e.g., newly-diagnosed PWH 
having their first HIV care visit), retention in care (e.g., having at least two HIV medical 
visits within a specified period of time), uptake of ART (e.g., initiating ART or time from 
diagnosis to initiated ART), and viral suppression (HIV viral load below a cut-off point 
defined by the authors of primary studies); and 3) conducted a statistical test to assess the 
association between service co-location and at least one of the aforementioned outcomes. 
Studies were excluded if they 1) only reported results from qualitative studies; 2) were 
systematic reviews, commentaries, editorials, or conference abstracts; or 3) were written in 
non-English languages. Citations were screened initially by title/abstract and included 
citations were further screened with full reports to confirm eligibility.
Data abstraction
Using a standardized coding form, three coders abstracted the following information from 
each of the eligible studies based on full reports: study characteristics (e.g., location, 
objectives, setting, design, sample size, outcome measures, and limitations); participant 
characteristics; description of service co-location (e.g., services offered in addition to HIV 
medical care);and study findings (i.e., statistical tests and results of associations between 
service co-location and HIV care outcomes). The coders then met to compare abstracted 
information and resolved discrepancies via group consensus.
Determination of co-location models
Two coders independently reviewed the description of service co-location across all eligible 
studies and jointly came up with six co-location models that included two or more primary 
studies: HIV care co-located with 1) multiple ancillary services, 2) TB care, 3) non-HIV 
specific primary care, 4) drug abuse treatment, 5) prevention of mother to child transmission 
(PMTCT) services, and 6) mental health care. The pair together applied the coding scheme 
to each eligible study, based on which co-located services were described in a given study. 
Two other team members verified the coding of the co-location models.
Determination of study rigor
Few randomized controlled trials (RCTs) have been conducted to examine the effects of 
service co-location on HIV care outcomes, which may reflect the current state of the 
science. We opted to broadly assess the risk of bias, and used a three-tiered system (Liau et 
al., 2013) that classifies evidence based on the rigor of study designs. This three-tiered 
system was previously used to evaluate the research literature on engagement in care, which 
was at a comparable level of development as the co-location literature.
Three coders classified the eligible studies into one of the three tiers. RCTs were considered 
the most rigorous (Tier I) while studies that used a non-randomized comparison – either 
comparing pre- and post-outcomes or comparing against a separate group without 
randomization – were designated as Tier II. Studies that determined correlational 
associations from observational data were considered the least rigorous (Tier III) in terms of 
reducing selection bias. We summarized the findings (i.e., positive association, null 
association, and mixed findings defined below) with indication of tiers.
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Determination of study finding per outcome per study
Due to the heterogeneity in co-location models, study designs, outcome measures, analytic 
approaches, and the presentation of statistical results across studies, we conducted a 
qualitative synthesis rather than a meta-analysis. We used the following rules to determine a 
finding for each outcome per study. If unadjusted and adjusted findings were both reported, 
we focused on the adjusted findings. When studies reported multiple findings for a specific 
outcome due to utilizing equally valid multiple measures, we designated the evidence as: 1) 
a “positive association” if >50% of the results showed statistically significant (p<0.05) 
positive associations between co-location and the outcome; 2) a “mixed result” if 50% of the 
results showed statistically significant positive associations; and 3) a “null association” if 
<50% of the results showed statistically significant positive associations.
RESULTS
Study characteristics
The study selection process is summarized in Figure 1. Among the 36 studies included, 15 
studies (42%) were from the United States [U.S.] and 21 were international studies. U.S. 
studies were conducted in large cities with high HIV prevalence. International studies were 
primarily conducted in African countries (e.g., Kenya, Mozambique, South Africa, and 
Zambia). The study setting included various types of clinics and facilities such as HIV 
clinics, TB clinics, methadone maintenance clinics, medical centers, and antenatal clinics.
Over one-half (k=19) of the studies assessed ART uptake as an outcome, and 42% (k=15) 
assessed viral suppression as an outcome. Eight studies assessed retention in care and six 
assessed linkage to care outcomes. These care outcomes were operationalized in a variety of 
ways; this was particularly true for the retention outcome. Only three studies (8%) were 
RCTs (Tier I), 15 studies (42%) had a comparison (Tier II) and 18 studies (50%) reported 
correlational data (Tier III). Sample sizes varied substantially across studies (range: 24 to 
36,411).
Models of service co-location
Supplementary table summarizes characteristics of the 36 studies by six models of service 
co-location, presented in descending order by the number of studies that were conducted, 
and within a model by outcome. The model “HIV care co-located with multiple ancillary 
services” was the most frequently reported (k=11) and these studies were conducted mostly 
in the U.S. (k=9/11, 82%). Four out of the six studies of the model “HIV care co-located 
with drug abuse treatment” and both studies of the model “HIV care co-located with mental 
health care” were conducted in the U.S. “HIV care co-located with TB care” (k=8), “HIV 
care co-located with non-HIV specific primary care” (k=6), and “HIV care co-located with 
PMTCT” (k=3) were examined only in international studies.
Associations between service co-location and HIV care outcomes
Table 1 summarizes the 48 sets of findings reported in the 36 studies. Twenty-nine (60%) 
were positive associations between service co-location and HIV care outcomes, 18 (38%) 
were null associations, and one (2%) was of mixed findings. Fifty percent of the Tier I study 
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findings showed positive associations, compared to 63% of the Tier II study findings and 
60% of the Tier III study findings showing positive associations. Sixty-eight per cent of 
international studies’ findings and 50% of U.S. findings were positive associations.
With regard to each HIV care outcome, all (100%) of the six findings that reported linkage 
to care outcomes and almost three-quarters (74%) of the 19 findings that reported ART 
uptake were positive associations. For the eight findings on retention in care, 50% showed 
null associations, 37.5% showed positive associations, 12.5% was of mixed results. For the 
15 findings on viral suppression, 60% showed null associations and 40% showed positive 
associations.
Differences by co-location model
Table 2 summarizes the associations between co-location and HIV care outcomes by the six 
co-location models by counting the number of findings with positive association, null 
association or mixed findings. Eight of the 10 findings (80%) from the model “HIV care co-
located with non-HIV specific primary care” were positive associations. Among these eight 
positive findings, three were for linkage to care, one was for retention, and four were for 
ART uptake. Four of the five findings (80%) of “HIV care co-located with PMTCT” were 
positive associations; two positive findings were for linkage and the other two were for ART 
uptake. Six out of the eight findings (75%) of “HIV care co-located with TB treatment” were 
positive associations; all six positive associations were for ART uptake. Five of the nine 
findings (56%) of the model “HIV care co-located with drug abuse treatment” were positive 
associations; one positive association was for retention, two for ART uptake, and two for 
viral suppression. Five (38.5%) of the 13 findings of the model “HIV care co-located with 
multiple ancillary services” were positive associations; one positive association was for 
linkage, one for retention, and three for viral suppression. Findings from the models “HIV 
care co-located with mental health care” showed more null associations than positive 
associations (see Table 2).
DISCUSSION
Summary of findings and implications
Overall, there were more positive associations (60%) than null (38%) or mixed (2%) 
associations between service co-location and HIV care outcomes. More evidence of a 
positive association was seen for linkage (100%) and ART uptake (74%) outcomes, while 
more evidence of a null or mixed association was seen for retention (62.5%) and viral 
suppression (60%) outcomes. Tier II and III study findings were more likely to be positive 
than more rigorous Tier I study findings, and international studies’ findings were more likely 
to be positive than U.S. findings.
The co-location models that showed more (>70%) positive associations were those that also 
addressed non-HIV medical care issues, i.e., co-location with non-HIV specific primary 
care, with PMTCT, and with TB care, showing associations particularly with linkage and 
ART uptake outcomes. These were all tested in international settings, and this may explain 
one of the reasons why the international studies’ findings showed more positive associations. 
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It is noteworthy that the models of co-location with TB care and with drug abuse treatment 
were likely to be tested with more rigorous study designs (Tier II as opposed to Tier III) 
suggesting that the evidence for these models may be stronger. The findings for these models 
are consistent with findings of a meta-analysis conducted by Suthar and colleagues (2014). 
However, we also found inconclusive evidence that these models are effective in improving 
retention in care. It is plausible that service integration itself may not solve problems such as 
shortages of human resources and inadequate infrastructure that are often the main 
challenges in resource-limited international settings (Turan et al., 2015).
The models of co-location with drug abuse treatment and with mental health care were 
primarily tested in the U.S. The association between the model of co-location with drug 
abuse treatment and ART uptake appears slightly stronger than the association with retention 
in care or viral suppression. The model of co-location with mental health care showed more 
null than positive associations; however, the evidence is only based on three findings. A 
plausible reason is that some mentally ill patients might have already been well-connected to 
both mental health and HIV care and, as a result, service co-location might have a negligible 
effect for such a group (Sullivan et al., 2006). The model of co-location with multiple 
ancillary services was also primarily tested in the U.S. Although the model would be 
expected to simultaneously and holistically address multiple health and social needs of 
PWH, we observed fewer positive findings (38.5%) than null findings (53.8%).
Our review found more null (60%) than positive (40%) associations for viral suppression 
outcomes. It is not surprising as viral suppression is a more “distal” outcome in the sense 
that it requires PWH to be retained in HIV care and to strictly adhere to a medication 
regimen, thus merely co-locating services may not be sufficient to achieve this outcome. A 
significantly higher proportion of findings from U.S. studies (60%) than from international 
studies (10.7%) assessed viral suppression as an outcome, which may also explain one of the 
reasons why the U.S. studies’ findings showed fewer positive associations.
Limitations of the studies reviewed
Only three of the studies we reviewed were randomized controlled trials and most studies 
were not specifically designed to directly test whether service co-location improves HIV 
care outcomes. As noted above, cross-examination of associations and rigor of study design 
suggests that positive associations tended to be observed in less rigorous Tier II and Tier III 
studies. In addition, potential bias associated with study methodology (e.g., use of not 
strictly comparable comparison groups, selection bias and non-generalizability, missing data 
or poor data quality, small sample sizes) has been noted as a limitation in many of the 
studies. We also observed a lack of standardization for outcome measures, particularly for 
retention outcomes across these studies.
Limitations of this review
First, although we searched a comprehensive HIV, AIDS and STI literature database using 
more than 60 search terms (see Appendix for complete list) that broadly cover the concept of 
service co-location, we might have missed studies due to the evolving array of terms used to 
describe the research. Additionally, the search located non-English language literature that 
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we excluded at screening of title and abstract. Second, given the lack of studies with 
rigorous methodology, we opted to broadly assess the risk of bias based on study designs 
(i.e., a Tier system). Third, our methods to determine a study finding per outcome per study, 
specifically, the 50% cutoff point in case of multiple findings, is somewhat arbitrary. In 
addition, we treated different measures for the same outcome used across the studies equally 
when they could have different clinical meanings. Finally, due to the heterogeneity in study 
methods and outcome measures, we were unable to compare the strength of the association 
across studies. However, our findings were consistent with those of the meta-analysis 
conducted by Suthar and colleagues (2014) for the association between ART uptake and co-
location of HIV/TB as well as co-location of HIV/non- HIV primary care.
Research gaps and future directions
Despite the limitations, our findings show that service co-location has the potential to 
improve some HIV care outcomes, especially for linkage to care and ART uptake. However, 
more research with rigorous study des igns is needed in order to strengthen the evaluation of, 
and evidence for, service co-location. Further examination of whether service co-location is 
the best way of improving retention in care, medication adherence, and ultimately viral 
suppression, is also a welcome quest. Research that identifies the specific types of ancillary 
services to co-locate, and determines what types of models work best for specific sub-
populations, especially those requiring mental health care, will expand our understanding of 
how to use this structural intervention. Finally, studies that assess the relative cost-efficiency 
of these approaches (Sweeny et al., 2015) and answer program implementation questions 
(e.g., which co-located services should be provided by the same or different staff, what is the 
optimum number of staff needed and how should they be trained and supervised, how best to 
facilitate communication among staff providing different services, how service utilization 
data and medical records should be integrated into one data system, and how effective 
models of co-located services are adapted for different settings) will provide valuable 
insights for policy and program decisions.
CONCLUSION
This systematic review shows some evidence that service co-location that addresses HIV and 
non-HIV medical issues may improve linkage and ART uptake, but shows inconclusive 
evidence for retention and viral suppression. This review contributes to the evidence base 
demonstrating potential positive effects of structural interventions on HIV care outcomes.
Supplementary Material
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Figure 1. 
Study Flow Diagram
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